Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-06-24
1993-03-23
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514912, A61K 3135
Patent
active
051964490
ABSTRACT:
The anthocyanidins pelargonidin and delphidin, have been found to possess novel and unexpected activity in the ophthalmic field, specifically that they are active in reducing the permeability of ciliary body vessels. According to one aspect of the present invention there is provided a method of reducing the hyperpermeability of the ciliary body ocular vessels in a subject which comprises administering to the subject an effective dose of pelargonidin or delphidin. The invention further provides the use of pelargonidin or delphidin in the manufacture of pharmaceutical compositions for carrying out the method of treatment referred to above.
REFERENCES:
patent: 4925871 (1990-05-01), Gabetta et al.
Chem Abst. 94:71489t (1981) Kokai.
Conti Marisa
Magistretti Maria J.
Pifferi Giorgio
Fay Zohreh A.
IdB Holding SpA
Waddell Frederick E.
LandOfFree
Methods and pharmaceutical compositions for the treatment of oph does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and pharmaceutical compositions for the treatment of oph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and pharmaceutical compositions for the treatment of oph will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1352047